Patient, Physician, and Payment Predictors of Statin Adherence

Osterberg, 2005, Adherence to medication., N Engl J Med, 353, 487, 10.1056/NEJMra050100

Choudhry, 2008, Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients., Pharmacoepidemiol Drug Saf, 17, 1189, 10.1002/pds.1671

1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)., Lancet, 344, 1383

1998, Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels., N Engl J Med, 339, 1349, 10.1056/NEJM199811053391902

Downs, 1998, Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS., JAMA, 279, 1615, 10.1001/jama.279.20.1615

Sacks, 1996, The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators., N Engl J Med, 335, 1001, 10.1056/NEJM199610033351401

Shepherd, 1995, Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia., N Engl J Med, 333, 1301, 10.1056/NEJM199511163332001

Shrank, 2006, The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions., Arch Intern Med, 166, 332, 10.1001/archinte.166.3.332

Andrade, 1995, Discontinuation of antihyperlipidemic drugs–do rates reported in clinical trials reflect rates in primary care settings?, N Engl J Med, 332, 1125, 10.1056/NEJM199504273321703

Benner, 2002, Long-term persistence in use of statin therapy in elderly patients., JAMA, 288, 455, 10.1001/jama.288.4.455

Eriksson, 1998, Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care., J Intern Med, 243, 373, 10.1046/j.1365-2796.1998.00294.x

Gibson, 2006, Impact of statin copayments on adherence and medical care utilization and expenditures., Am J Manag Care, 12, S11

Schwed, 1999, Electronic monitoring of compliance to lipid-lowering therapy in clinical practice., J Clin Pharmacol, 39, 402, 10.1177/00912709922007976

Simons, 1996, Apparent discontinuation rates in patients prescribed lipid-lowering drugs., Med J Aust, 164, 208, 10.5694/j.1326-5377.1996.tb94138.x

Jackevicius, 2002, Adherence with statin therapy in elderly patients with and without acute coronary syndromes., JAMA, 288, 462, 10.1001/jama.288.4.462

Haynes, 2008, Interventions for enhancing medication adherence., Cochrane Database Syst Rev, CD000011

Fendrick, 2001, A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost., Am J Manag Care, 7, 861

Goldman, 2006, Varying pharmacy benefits with clinical status: the case of cholesterol-lowering therapy., Am J Manag Care, 12, 21

Choudhry, 2008, Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies., Am Heart J, 156, 31, 10.1016/j.ahj.2008.03.021

Piette, 2006, A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures., Soc Sci Med, 62, 846, 10.1016/j.socscimed.2005.06.045

Glasgow, 2000, A social-ecologic approach to assessing support for disease self-management: the Chronic Illness Resources Survey., J Behav Med, 23, 559, 10.1023/A:1005507603901

Horne, 1999, Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness., J Psychosom Res, 47, 555, 10.1016/S0022-3999(99)00057-4

Shikiar, 2004, Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues., Value Health, 7, 204, 10.1111/j.1524-4733.2004.72252.x

Goldman, 2007, Prescription drug cost sharing: associations with medication and medical utilization and spending and health., JAMA, 298, 61, 10.1001/jama.298.1.61

Steiner, 1997, The assessment of refill compliance using pharmacy records: methods, validity, and applications., J Clin Epidemiol, 50, 105, 10.1016/S0895-4356(96)00268-5

Zeger, 1986, Longitudinal data analysis for discrete and continuous outcomes., Biometrics, 42, 121, 10.2307/2531248

Rand, 1971, Objective criteria for the evaluation of clustering methods., J Am Stat Assoc, 66, 846, 10.1080/01621459.1971.10482356

D'Agostino, 2001, Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation., JAMA, 286, 180, 10.1001/jama.286.2.180

Hosmer, 2000, Applied Logistic Regression., 10.1002/0471722146

Goldman, 2004, Pharmacy benefits and the use of drugs by the chronically ill., JAMA, 291, 2344, 10.1001/jama.291.19.2344

Brookhart, 2007, Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use., Arch Intern Med, 167, 847, 10.1001/archinte.167.8.847

Ammassari, 2002, Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature., J Acquir Immune Defic Syndr, 31, S123, 10.1097/00126334-200212153-00007

Stilley, 2004, Psychological and cognitive function: predictors of adherence with cholesterol lowering treatment., Ann Behav Med, 27, 117, 10.1207/s15324796abm2702_6

Leibowitz, 1985, The demand for prescription drugs as a function of cost-sharing., Soc Sci Med, 21, 1063, 10.1016/0277-9536(85)90161-3

Altice, 2001, Trust and the acceptance of and adherence to antiretroviral therapy., J Acquir Immune Defic Syndr, 28, 47, 10.1097/00042560-200109010-00008

Piette, 2005, The role of patient-physician trust in moderating medication nonadherence due to cost pressures., Arch Intern Med, 165, 1749, 10.1001/archinte.165.15.1749